Protocol detail

Mortality Risk Factors Across Causes

Find Similar Protocols

Overall mortality was the primary outcome and defined as death due to any cause during follow-up, including diseases of heart (I00-I09, I11, I13, I20-I51), malignant neoplasms (C00-C97), chronic lower respiratory diseases (J40-J47), accidents (unintentional injuries) (V01-X59, Y85-Y86), cerebrovascular diseases (I60-I69), Alzheimer’s disease (G30), Diabetes mellitus (E10-E14), influenza and pneumonia (J09-J18), nephritis, nephrotic syndrome and nephrosis (N00-N07, N17-N19, N25-N27), all other causes (residual). Follow-up commenced at the baseline examination date. CVD mortality was considered as the secondary outcome and included death due to diseases of heart (I00-I09, I11, I13, I20-I51). The comprehensive information on this program and its procedures were published on the NHANES website (

https://www.cdc.gov/nchs/nhanes/

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Xiao S., Wang Z., Zuo R., Zhou Y., Yang Y., Chen T, & Liu N. (2023). Association of Systemic Immune Inflammation Index with All-Cause, Cardiovascular Disease, and Cancer-Related Mortality in Patients with Cardiovascular Disease: A Cross-Sectional Study. Journal of Inflammation Research, 16, 941-961.

Publication 2023

Accidents Cerebrovascular diseases Diabetes mellitus Heart death Heart diseases Influenza Malignant neoplasms Nephritis Nephrosis Pneumonia Respiratory diseases Unintentional injuries

Top 5 similar protocols

Variable analysis

independent variables

Independent variables not explicitly mentioned.

dependent variables

Overall mortality: Death due to any cause during follow-up, including diseases of heart (I00-I09, I11, I13, I20-I51), malignant neoplasms (C00-C97), chronic lower respiratory diseases (J40-J47), accidents (unintentional injuries) (V01-X59, Y85-Y86), cerebrovascular diseases (I60-I69), Alzheimer's disease (G30), Diabetes mellitus (E10-E14), influenza and pneumonia (J09-J18), nephritis, nephrotic syndrome and nephrosis (N00-N07, N17-N19, N25-N27), all other causes (residual).
CVD mortality: Death due to diseases of heart (I00-I09, I11, I13, I20-I51).

control variables

Control variables not explicitly mentioned.

controls

No positive or negative controls were specified by the authors.

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!